Suppr超能文献

对乙酰氨基酚给药可降低艰难梭菌感染重症患者的急性肾损伤风险:一项队列研究。

Acetaminophen administration reduces acute kidney injury risk in critically ill patients with Clostridium difficile infection: A cohort study.

作者信息

Liao Yue, Wang Yulong, Li Daxue, Qiu Xuewen

机构信息

Department of Pharmacy, Chongqing General Hospital, Chongqing University, Chongqing, China.

Department of Ophthalmology, Chongqing General Hospital, Chongqing University, Chongqing, China.

出版信息

PLoS One. 2024 Dec 30;19(12):e0314902. doi: 10.1371/journal.pone.0314902. eCollection 2024.

Abstract

BACKGROUND

Acetaminophen serves as a standard antipyretic and analgesic agent in the intensive care unit (ICU). However, the association between its administration and acute kidney injury (AKI) among critically ill patients remains controversial, particularly lacking research in patients with Clostridioides difficile infection (CDI). Our aim was to explore the potential relationship between early acetaminophen administration and AKI in critically ill patients with concurrent CDI.

METHODS

Using data from the Medical Information Mart for Intensive Care (MIMIC) IV version 2.2 database, we performed a retrospective cohort study. AKI within 7 days of ICU admission was the main outcome that was measured. We utilized multivariable logistic regression models adjusted for potential confounders based on statistical significance and clinical relevance, to investigate the association between acetaminophen exposure and the risk of AKI in patients with CDI. Additionally, subgroup analyses and sensitivity analysis were conducted to assess the robustness of our primary findings.

RESULTS

The average age of 984 participants was 66.8 ± 16.5 years, and 52.7% (519) were male. The overall proportion of patients who developed AKI was 75.4% (742/984). In patients without and with acetaminophen administration, AKI rates were 79.8% (380/476) and 71.3% (362/508), respectively. Compared to the non-acetaminophen administration group, the risk of AKI was lower in the acetaminophen administration group (absolute risk difference: -8.5%, 95%CI: -13.83%∼-3.17%, P < 0.01).After adjusting for potential confounders, acetaminophen administration was associated with a 32% reduction in the risk of AKI (OR = 0.68, 95%CI:0.48∼0.96, P = 0.027).

CONCLUSION

Our study suggests that early acetaminophen administration may offer renal protection by reducing the risk of AKI in critically ill patients with CDI. Prospective, multicenter randomized controlled studies are needed to verify this finding.

摘要

背景

对乙酰氨基酚是重症监护病房(ICU)中标准的解热镇痛药。然而,其给药与危重症患者急性肾损伤(AKI)之间的关联仍存在争议,尤其是缺乏针对艰难梭菌感染(CDI)患者的研究。我们的目的是探讨在合并CDI的危重症患者中早期使用对乙酰氨基酚与AKI之间的潜在关系。

方法

利用重症监护医学信息集市(MIMIC)IV版2.2数据库中的数据,我们进行了一项回顾性队列研究。测量的主要结局是ICU入院7天内发生的AKI。我们使用基于统计学意义和临床相关性对潜在混杂因素进行调整的多变量逻辑回归模型,来研究对乙酰氨基酚暴露与CDI患者AKI风险之间的关联。此外,进行了亚组分析和敏感性分析以评估我们主要发现的稳健性。

结果

984名参与者的平均年龄为66.8±16.5岁,52.7%(519名)为男性。发生AKI的患者总体比例为75.4%(742/984)。在未使用和使用对乙酰氨基酚的患者中,AKI发生率分别为79.8%(380/476)和71.3%(362/508)。与未使用对乙酰氨基酚组相比,使用对乙酰氨基酚组的AKI风险较低(绝对风险差异:-8.5%,95%CI:-13.83%∼-3.17%,P<0.01)。在对潜在混杂因素进行调整后,使用对乙酰氨基酚与AKI风险降低32%相关(OR=0.68,95%CI:0.48∼0.96,P=0.027)。

结论

我们的研究表明,早期使用对乙酰氨基酚可能通过降低合并CDI的危重症患者发生AKI的风险来提供肾脏保护。需要进行前瞻性、多中心随机对照研究来验证这一发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dbb/11684698/fc87ffa20771/pone.0314902.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验